NCT05421130View on ClinicalTrials.gov

Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair

NAUnknownINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

February 1, 2024

Conditions
Aortic AneurysmAortic DissectionAortic Arch AneurysmAortic Arch; Aneurysm, Dissecting
Interventions
DEVICE

Selective Cerebral Perfusion Catheter

This product is intended to be placed in the branches of the aortic arch for the cerebral perfusion during surgery of aorta.

Trial Locations (5)

60590

Universitätsklinikum Frankfurt, Frankfurt

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

04289

Herzzentrum Leipzig GmbH, Leipzig

Unknown

St.Antonius Hospital, Nieuwegein

6500HB

Radboud universitair medisch centrum, Nijmegen

Sponsors

Collaborators (1)

Avania
All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

Fuji Systems Corporation

INDUSTRY

NCT05421130 - Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair | Biotech Hunter | Biotech Hunter